Trial intelligence / Profile preview

Ciprofol versus propofol in cardiac surgery with cardiopulmonary bypass

ChiCTR2200061712Phase 4Recruiting

Sponsor
Affiliated Hospital of Guizhou Medical University
Start
Nov 2022
Modality
Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of ciprofol and propofol in cardiac disease (2 arms), sponsored by Affiliated Hospital of Guizhou Medical University. Primary endpoint: Incidence of perioperative neurocognitive disorders. Started Nov 2022; status: recruiting.

02

Drugs

ciprofolpropofol
03

Conditions

cardiac disease

Beyond the preview

Go deeper on ChiCTR2200061712.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200061712.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call